Polymorphisms of platelet ADP receptor P2RY12 in the risk of venous thromboembolism in the Korean population.

Abstract

Although it was thought that platelets did not play a significant role in the pathogenesis of venous thromboembolism (VTE), several studies demonstrated that a marked activation of platelets occurs in patients with VTE. We carried out a case-control study to investigate the effect of the T744C P2RY12 polymorphism on the risk of VTE in the Korean population. We enrolled 154 consecutive patients with VTE and 415 healthy controls. Genotype frequencies for patients with TT, TC, and CC were 71.4%, 24.7%, and 3.9% and in the controls, 68.2%, 30.1%, and 1.7%, respectively. T744C P2RY12 polymorphism did not significantly affect the risk of VTE. Our study shows that T744C P2RY12 polymorphism did not significantly affect the risk of VTE in the Korean population.

• Authors: Moon Ju Jang, Young Joo Jeon, Kyung Tae Min, Jisu Oh, So Young Chong, Seonyang Park, Hye Sook Yun-Choi, Doyeun Oh, Nam Keun Kim
• Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (Clin Appl Thromb Hemost) Vol. 18 Issue 4 Pg. 416-20 (Jul 2012) ISSN: 1938-2723 [Electronic] United States
• PMID: 22275393 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• P2RY12 protein, human
• Receptors, Purinergic P2Y12

Topics

• Aged
• Asian People
• Case-Control Studies
• Female
• Humans
• Male
• Middle Aged
• Polymorphism, Genetic
• Receptors, Purinergic P2Y12 (genetics)
• Republic of Korea
• Risk Factors
• Thromboembolism (genetics)